Abstract

This study describes the nerve entry point and intramuscular nerve branching of the rhomboid major and minor, providing essential information for improved performance of botulinum toxin injections and electromyography. A modified Sihler method was performed on the rhomboid major and minor muscles (10 specimens each). The nerve entry point and intramuscular arborization areas were identified in terms of the spinous processes and medial and lateral angles of the scapula. The nerve entry point for both the rhomboid major and minor was found in the middle muscular area between levels C7 and T1. The intramuscular neural distribution for the rhomboid minor had the largest arborization patterns in the medial and lateral sections between levels C7 and T1. The rhomboid major muscle had the largest arborization area in the middle section between levels T1 and T5. In conclusion, botulinum neurotoxin injection and electromyography should be administered in the medial and lateral sections of C7−T1 for the rhomboid minor and the middle section of T1−T7 for the rhomboid major. Injections in the middle section of C7−T1 should also be avoided to prevent mechanical injury to the nerve trunk. Clinicians can administer safe and effective treatments with botulinum toxin injections and other types of injections by following the methods in our study.

Highlights

  • Spasticity is a major contributor to movement disorders involving central nervous system impairment, such as stroke and brain injury [1]

  • The rhomboid major and minor muscles are the core muscles targeted for treatment in patients with shoulder spasticity [4]

  • We recommend that clinicians perform injections at multiple sites with a low dose of Botulinum toxin (BoNT) for maximum effect and to avoid side effects

Read more

Summary

Introduction

Spasticity is a major contributor to movement disorders involving central nervous system impairment, such as stroke and brain injury [1]. Patients with hemiplegic neurologic impairment frequently suffer from shoulder spasticity, which limits shoulder movement and causes shoulder pain [2,3,4,5]. The rhomboid major and minor muscles are the core muscles targeted for treatment in patients with shoulder spasticity [4]. Involuntary activations of spastic rhomboid muscles cause the scapula to be in an elevated and medially rotated position [6]. The reduction of involuntary activations in spastic rhomboid muscles may result in proper positioning of the scapula with coordinated movement of the glenohumeral joint. Botulinum toxin (BoNT) is considered a leading therapy for the reduction of Toxins 2020, 12, 289; doi:10.3390/toxins12050289 www.mdpi.com/journal/toxins

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call